In a recent report, the American Academy of Pediatrics offered updated guidance for treating and managing head lice.
The American Academy of Pediatrics (AAP) has updated their guidelines on the diagnosis and treatmentof head lice for the first time since 2015, bringing attention to the stigma and psychological stress surrounding the condition.
“Head lice are an unpleasant part of the human experience, but they can be successfully managed and are no reason for a child to miss school,” said Dawn Nolt, MD, MPH, FAAP, lead author of the report “Head Lice”, which was published in the October 2022 edition of Pediatrics.
New medications to treat head lice and a guide for management are written in the report. Nolt encouraged pediatricians to help families, school districts, and communities to allow treatment of head lice to take place without stigma.
Head lice is often treated with topical agents, such as shampoos, lotions and other Food and Drug Administration-approved products that contain pyrethroids. However, there are others forms of treatment which the AAP outlines in their report.
The AAP discouraged head lice screening programs in schools which have not been associated with significant effects, are not cost effective, and may lead to stigma surrounding head lice. Instead, the AAP recommended schools offer educational programs that can help families understand and manage head lice in their community.
Treatments should be safe and age appropriate, along with being affordable and quickly able to remove live lice and nits, according to the AAP. They encouraged parents to call their pediatrician for proper diagnosis and product use.
Reference
American Academy of Pediatrics updates report on controlling and treating head lice in children, adolescents. American Academy of Pediatrics. September 26, 2022. Accessed September 23, 2022. https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-updates-report-on-controlling-and-treating-head-lice-in-children-adolescents/
AAP recommends all infants receive nirsevimab to fight RSV
August 15th 2023The recommendation from the American Academy of Pediatrics (AAP) follows the unanimous recommendation by the CDC advisory group for routine use of nirsevimab in newborns and infants younger than 8 months born into or entering their first RSV season.
American Academy of Pediatrics’ guidance for organ donation and transplantation
August 1st 2023Updated guidance for pediatricians that interact with children and their families, who need a potentially life-saving organ donation or transplantation, has been released by the American Academy of Pediatrics (AAP).
How pediatricians can support patients exposed to intimate partner violence
June 26th 2023About 1 in 4 children are exposed to intimate partner violence (IPV) in their lifetime, according to the American Academy of Pediatrics. The AAP has released tips and recommendations for pediatricians to help support these patients and their families.